Results

Total Results: 1,518 records

Showing results for "symptom".

1. Cer-276-Ocd-Appendix-H (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-h.xlsx
   January 01, 2023 - ) 269 12.8 (2.7) 24.6 (5.1) Behavioral ERP/Exposure exposure-based CBT Yes Yes 20 13 Adequate OCD symptom … ) 269 12.8 (2.7) 24.6 (5.1) Behavioral ERP/Exposure exposure-based CBT Yes Yes 20 13 Adequate OCD symptom … ) 269 12.8 (2.7) 24.6 (5.1) Behavioral ERP/Exposure exposure-based CBT Yes Yes 20 13 Adequate OCD symptom … ) 269 12.8 (2.7) 24.6 (5.1) Behavioral ERP/Exposure exposure-based CBT Yes Yes 20 13 Adequate OCD symptom … ) 269 12.8 (2.7) 24.6 (5.1) Behavioral ERP/Exposure exposure-based CBT Yes Yes 20 13 Adequate OCD symptom

2. Ptsd-Adults-Trauma-Interventions Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adults-trauma-interventions_executive.pdf
   April 01, 2013 - Our outcomes of interest focused on the incidence of PTSD and PTSD- related symptoms; PTSD symptom severity … For continuous outcomes (e.g., scales for symptom reduction), we used weighted mean differences (WMD … severity CC produces a greater decrease in PTSD symptom severity at 6, 9, and 12 months after injury … All other findings for incidence of PTSD or PTSD symptom severity were graded as having insufficient … severity in adults with ASD; CC may be helpful for reducing PTSD symptom severity post-injury; and

3. Appendix Table B-1. RCTs of Masks (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
   April 09, 2020 - C Index cases Symptom onset to randomization interval 12-24 hrs: 46% vs. 52% vs. 59% Randomization to … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … and a systemic symptom A. 7.2% (42/581) B. 11.8% (61/516) A or B: 9.4% (103/1097) C. 17.1% (98/572)

4. Masks-Surveillance-2-Appendix-Table-A-1 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
   April 09, 2020 - C Index cases Symptom onset to randomization interval 12-24 hrs: 46% vs. 52% vs. 59% Randomization to … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … and a systemic symptom A. 7.2% (42/581) B. 11.8% (61/516) A or B: 9.4% (103/1097) C. 17.1% (98/572)

5. Masks-Appendix-Table-B-1-Version-2 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
   April 09, 2020 - C Index cases Symptom onset to randomization interval 12-24 hrs: 46% vs. 52% vs. 59% Randomization to … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … and a systemic symptom A. 7.2% (42/581) B. 11.8% (61/516) A or B: 9.4% (103/1097) C. 17.1% (98/572)

6. Masks-Appendix-Table-B-1-Surveillance-Report (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
   April 09, 2020 - C Index cases Symptom onset to randomization interval 12-24 hrs: 46% vs. 52% vs. 59% Randomization to … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … C when restricted to contacts of index cases receiving intervention within 36 hours of symptom onset … and a systemic symptom A. 7.2% (42/581) B. 11.8% (61/516) A or B: 9.4% (103/1097) C. 17.1% (98/572)

7. Layout 1 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
   September 01, 2011 - Subjective outcomes include symptom frequency and severity, sleep/productivity, and overall quality of … No consistent comparative difference in symptom relief was observed between esomeprazole (20 to 40 mg … No significant difference in symptom resolution rates was observed at 4 weeks between esomeprazole 20 … Continuous daily intake of esomeprazole 20 mg appeared to provide better symptom control and quality … Pantoprazole 40 mg and rabeprazole 20 mg provided significantly better symptom relief and healing of

8. Evidence Summary: CER 237_Integrating Palliative Care in Ambulatory Care of Noncancer Serious Chronic Illness (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/cer-237-evidence-summary-palliative-care-ambulatory.pdf
   February 01, 2021 - Care for these patients can be complex, as the patients often experience high symptom burden and decreased … models evaluated for integrating palliative care may have little to no effect on reducing overall symptom … were not more effective than usual care for improving health-related quality of life or depressive symptom … Models for integrating palliative care may have little to no effect on overall symptom burden and were … not effective for patient health-related quality of life or depressive symptom scores, but did increase

9. Technical Brief No. 35, Characteristics of Existing Asthma Self-Management Education Packages - Summary (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/asthma-self-mgmt-summary.pdf
   April 01, 2020 -  Packages address asthma knowledge, medication and device use, symptom management, and asthma …  Many packages include useful tools such as Asthma Action Plans, symptom or medication logs, … and checklists to monitor exposure to asthma symptom triggers …  AS-ME packages generally improved asthma control, reduced symptom frequency, increased asthma knowledge

10. Cer-276-Ocd-Appendix-G (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-g.xlsx
    January 01, 2022 - TP FN FP TN N_calc Effect Modifier Effect Modifier Results 27283942 Piqueras 2017 DWS C-FOCI C-FOCI symptom … checklist 1 94 NA 1 100 OCD only 94 0 none NA 27283942 Piqueras 2017 DWS C-FOCI C-FOCI symptom … checklist 4 94 NA 0.9 90 OCD only 85 9 none NA 27283942 Piqueras 2017 DWS C-FOCI C-FOCI symptom … 62 NA 0.6613 66.13 OCD only 41 21 none NA 2021-61128-001 Zemestani 2021 DWS C-FOCI C-FOCI symptom … 62 NA 0.9355 93.55 OCD only 58 4 none NA 2021-61128-001 Zemestani 2021 DWS C-FOCI C-FOCI symptom

11. Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
    January 01, 2011 - the best treatment: Clinical Outcome Adverse Events Out-of-Pocket Costs Drug A symptom … Outcome C1 = 0.5 Adverse Events C2 = 0.33 Out-of-Pocket Costs C3 = 0.17 Drug A symptom … Goal: Select best drug treatment’ a decision matrix is highlighted that includes: Clinical benefit (symptom … Clinical Benefit (symptom relieve due drug use) Impact of Treatment (e.g. drug requires complex dosing … 3 4 5 6 7 8 9 Goal: Select the best drug treatment—this text is highlighted Clinical benefit (symptom

12. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment_research-protocol.pdf
    December 20, 2011 - Modified PTSD Symptom Scale (MPSS-SR). … PTSD Symptom Scale - Interview (PSS-I). … • Each item corresponds to a DSM-IV symptom of PTSD, and each symptom is rated in terms of frequency … • This scale is a modification of the PTSD Symptom Scale. … • It can be scored as a continuous measure of PTSD symptom severity.

13. Eising_Panel_2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/eising_panel_2.pdf
    January 01, 2010 - their health information-­‐seeking goals and tactics o Phase — Self-­‐diagnosis (identify cause of symptom … ) o Phase — Confirm suspected  cause of symptom o Phase — Confirm diagnosis and  supplement provider

14. Allergy-Seasonal Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
    July 01, 2013 - Thus, pharmacotherapy is preferable to allergen avoidance for SAR symptom relief. … For those codiagnosed with asthma, does pharmacologic treatment of SAR provide asthma symptom relief … One group defined a distribution-based MCID for total nasal symptom score (TNSS) as 0.52 on a 0-12 … measures, namely the four-symptom TNSS and the three-item TOSS. … Widely used symptom rating scales require standardization and validation.

15. Restless-Legs Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - Yet, relief is temporary, and symptoms return when movement ceases.3 RLS varies in symptom severity … Augmentation is characterized by greater symptom intensity, onset earlier in the day, and shorter … We evaluated RLS symptom severity and outcome, patient-reported sleep quality, and disease-specific … Pneumatic compression devices18 reduced IRLS symptom scale scores more than sham (moderate-strength … Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?

16. Psychological and Pharmacological Treatments for Adults with Posttraumatic (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment-update_research-protocol.pdf
    December 31, 2017 - Modified PTSD Symptom Scale (MPSS-SR). … PTSD Symptom Scale - Interview (PSS-I). … • Each item corresponds to a DSM-IV symptom of PTSD, and each symptom is rated in terms of frequency … • This scale is a modification of the PTSD Symptom Scale. … • It can be scored as a continuous measure of PTSD symptom severity.

17. Medical Therapies for Children With Autism Spectrum Disorder—An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-executive-170505.pdf
    May 01, 2017 - What characteristics (e.g., age, symptom severity), if any, of the child modify the effectiveness of … In two small trials, bumetanide plus applied behavior analysis improved symptom severity more than … Tetrahydrobiopterin had no effect on symptom severity and was not associated with clinically significant … Studies of pharmacological agents often sampled children with high levels of specific symptom patterns … Populations across studies were heterogeneous in terms of challenging behaviors, ASD symptom severity

18. Lung-Cancer-Nonsurgical-Therapies Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
    June 01, 2013 - The evidence for symptom Table C. … The evidence for symptom relief, survival, and treatment-related toxicities was imprecise. … The evidence for symptom relief, survival, and treatment-related toxicities was imprecise. … The outcomes measured in the study—survival and symptom relief— were direct. … The evidence for symptom relief and survival was imprecise.

19. Amended Protocol: Interventions for Breathlessness in Patients with Advanced Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
    May 19, 2020 - Guidelines support comprehensive symptom assessment and treatment as consistent with patient preferences … outcomes (KQ1-3) Caregiver-reported or observational symptom-related only if patients are unable to … Symptom prevalence in lung and colorectal cancer patients. … J Pain Symptom Manage. 2015 Feb;49(2):192-202. doi: 10.1016/j.jpainsymman.2014.06.003. … J Pain Symptom Manage. 2019 Apr 17. doi: 10.1016/j.jpainsymman.2019.04.011. PMID: 31004769. 5.

20. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
    May 19, 2010 - Outcomes: For efficacy, we will report commonly used objective outcomes such as symptom scores, response … For the efficacy, we will report commonly used objective outcomes such as symptom scores, response rates … May 19, 2010 PTSD, depression, etc.) via the examination of selected outcome measures, mainly symptom … ADD-H Comprehensive Teachers Rating Scale (ACTeRS) ADDES-Secondary Age ADHD Rating Scale-IV ADHD Symptom … ADHD Rating Scales (CAARS) Conners' Comprehensive Behavior Rating Scales (Conners CBRS) Copeland Symptom